Efficacy of journaling in the management of mental illness: a systematic review and meta-analysis.

IF 4.7 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2022-03-01 DOI:10.1136/fmch-2021-001154
Monika Sohal, Pavneet Singh, Bhupinder Singh Dhillon, Harbir Singh Gill
{"title":"Efficacy of journaling in the management of mental illness: a systematic review and meta-analysis.","authors":"Monika Sohal, Pavneet Singh, Bhupinder Singh Dhillon, Harbir Singh Gill","doi":"10.1136/fmch-2021-001154","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Journaling is a common non-pharmacological tool in the management of mental illness, however, no clear evidence-based guideline exists informing primary care providers on its use. We seek here to present this synthesis that may begin to inform future research and eventual evidence-based guideline development.</p><p><strong>Design: </strong>Of the 3797 articles retrieved from MEDLINE, EMBASE, PsycINFO, 20 peer-reviewed randomised control trials (31 outcomes) met inclusion criteria. These studies addressed the impact of a journaling intervention on PTSD, other anxiety disorders, depression or a combination of the aforementioned.</p><p><strong>Eligibility criteria: </strong>Peer reviewed, randomised control trials on the impact of journaling on mental illness were included.</p><p><strong>Information sources: </strong>MEDLINE, EMBASE and PsycINFO.</p><p><strong>Results: </strong>The data are highly heterogeneous (control arm=I<sup>2</sup> of 71.2%, intervention arm=I<sup>2</sup> of 83.8%) combined with a B-level Strength of Recommendation Taxonomy recommendation. It was additionally found that there is a significant pre-post psychometric scale difference between control (-0.01, 95% CI -0.03 to 0.00) and intervention arms (-0.06, 95% CI -0.09 to -0.03). This 5% difference between groups indicates that a journaling intervention resulted in a greater reduction in scores on patient health measures. Cohen's d effect size analysis of studies suggests a small to moderate benefit.</p><p><strong>Conclusion: </strong>Further studies are needed to better define the outcomes. Our review suggests that while there is some randomised control data to support the benefit of journaling, high degrees of heterogeneity and methodological flaws limit our ability to definitively draw conclusions about the benefit and effect size of journaling in a wide array of mental illnesses. Given the low risk of adverse effects, low resource requirement and emphasis on self-efficacy, primary care providers should consider this as an adjunct therapy to complement current evidence-based management.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935176/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/fmch-2021-001154","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Journaling is a common non-pharmacological tool in the management of mental illness, however, no clear evidence-based guideline exists informing primary care providers on its use. We seek here to present this synthesis that may begin to inform future research and eventual evidence-based guideline development.

Design: Of the 3797 articles retrieved from MEDLINE, EMBASE, PsycINFO, 20 peer-reviewed randomised control trials (31 outcomes) met inclusion criteria. These studies addressed the impact of a journaling intervention on PTSD, other anxiety disorders, depression or a combination of the aforementioned.

Eligibility criteria: Peer reviewed, randomised control trials on the impact of journaling on mental illness were included.

Information sources: MEDLINE, EMBASE and PsycINFO.

Results: The data are highly heterogeneous (control arm=I2 of 71.2%, intervention arm=I2 of 83.8%) combined with a B-level Strength of Recommendation Taxonomy recommendation. It was additionally found that there is a significant pre-post psychometric scale difference between control (-0.01, 95% CI -0.03 to 0.00) and intervention arms (-0.06, 95% CI -0.09 to -0.03). This 5% difference between groups indicates that a journaling intervention resulted in a greater reduction in scores on patient health measures. Cohen's d effect size analysis of studies suggests a small to moderate benefit.

Conclusion: Further studies are needed to better define the outcomes. Our review suggests that while there is some randomised control data to support the benefit of journaling, high degrees of heterogeneity and methodological flaws limit our ability to definitively draw conclusions about the benefit and effect size of journaling in a wide array of mental illnesses. Given the low risk of adverse effects, low resource requirement and emphasis on self-efficacy, primary care providers should consider this as an adjunct therapy to complement current evidence-based management.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
日记在精神疾病管理中的作用:系统综述和荟萃分析
日志是精神疾病管理中一种常见的非药物工具,然而,目前尚无明确的循证指南告知初级保健提供者如何使用日志。我们在此寻求提出这一综合,可能开始为未来的研究和最终的循证指南制定提供信息。从MEDLINE、EMBASE、PsycINFO检索的3797篇文献中,有20项同行评议的随机对照试验(31个结果)符合纳入标准。这些研究探讨了日记干预对创伤后应激障碍、其他焦虑症、抑郁症或上述综合疾病的影响。入选标准:同行评议的、关于日志对精神疾病影响的随机对照试验被纳入。信息来源MEDLINE, EMBASE和PsycINFO。结果数据具有高度异质性(对照组=I2 = 71.2%,干预组=I2 = 83.8%),推荐强度为b级。另外还发现,在对照组(- 0.01,95% CI - 0.03至0.00)和干预组(- 0.06,95% CI - 0.09至- 0.03)之间存在显著的心理测量量表前后差异。这5%的组间差异表明,日志干预导致患者健康指标得分下降幅度更大。科恩对研究的效应大小分析表明,这种益处小到中等程度。结论需要进一步的研究来更好地定义预后。我们的综述表明,虽然有一些随机对照数据支持日志的好处,但高度的异质性和方法缺陷限制了我们明确得出关于日志对多种精神疾病的好处和效果大小的结论的能力。鉴于不良反应风险低,资源需求低,强调自我效能,初级保健提供者应考虑将其作为辅助治疗,以补充当前循证管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊介绍: ACS Applied Bio Materials is an interdisciplinary journal publishing original research covering all aspects of biomaterials and biointerfaces including and beyond the traditional biosensing, biomedical and therapeutic applications. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrates knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important bio applications. The journal is specifically interested in work that addresses the relationship between structure and function and assesses the stability and degradation of materials under relevant environmental and biological conditions.
期刊最新文献
Retraction of "Real-Time Monitoring of Mitochondrial pH in HeLa Cells, Drosophila melanogaster, and Zebrafish Larvae Using BODIPY-Based Ratiometric Fluorescent Probes". Correction to "Systemic microRNA Delivery Using Polysaccharide-Coated Nanobubbles for Ultrasound-Mediated Therapy of Triple-Negative Breast Cancer". Green Marine Collagen-Chitosan Composites with Biocompatible, Hemostatic, and Pro-Healing Performance. Hierarchical Logic Control via DNA Polymerase-Driven Molecular Circuits. Silk Protein-Based Materials for Photothermal Therapy: From Morphologies to Multifunctional Applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1